XORTX Therapeutics Inc (XRTX)

Currency in USD
0.7750
+0.0440(+6.02%)
Closed·
XRTX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
XRTX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.75000.8000
52 wk Range
0.66082.9799
Key Statistics
Prev. Close
0.7352
Open
0.8
Day's Range
0.75-0.8
52 wk Range
0.6608-2.9799
Volume
164.21K
Average Volume (3m)
105.96K
1-Year Change
-51.63%
Book Value / Share
0.72
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
XRTX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

XORTX Therapeutics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Buy

XORTX Therapeutics Inc Company Profile

XORTX Therapeutics Inc., a late-stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat gout and progressive kidney disease. Its drug development programs include XRx-026, which is in the third phase for the treatment of gout; XRx-008, which is in the second phase to treat autosomal dominant polycystic kidney disease; XRx-101, which is in the second phase to treat acute kidney injury associated with respiratory virus infection; and XRX-225, which is in the preclinical stage for the treatment of type 2 diabetic nephropathy. It has a license agreement with the University of Florida Research Foundation, Inc. for the use of uric acid lowering agent to treat insulin resistance. The company is based in Calgary, Canada.

Compare XRTX to Peers and Sector

Metrics to compare
XRTX
Peers
Sector
Relationship
P/E Ratio
−4.0x−0.3x−0.5x
PEG Ratio
−0.050.000.00
Price/Book
1.4x0.6x2.6x
Price / LTM Sales
-1.4x3.3x
Upside (Analyst Target)
-17.0%43.5%
Fair Value Upside
Unlock15.8%6.9%Unlock

Earnings

Latest Release
May 16, 2025
EPS / Forecast
-0.19 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

XRTX Income Statement

People Also Watch

0.587
WINT
+4.63%
41.28
BMNR
+7.30%
0.033
NCNA
-18.81%
1.520
MBIO
+3.40%
5.48
REPL
-0.36%

FAQ

What Stock Exchange Does XORTX Therapeutics Trade On?

XORTX Therapeutics is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for XORTX Therapeutics?

The stock symbol for XORTX Therapeutics is "XRTX."

What Is the XORTX Therapeutics Market Cap?

As of today, XORTX Therapeutics market cap is 3.94M.

What Is XORTX Therapeutics's Earnings Per Share (TTM)?

The XORTX Therapeutics EPS (TTM) is -0.31.

From a Technical Analysis Perspective, Is XRTX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has XORTX Therapeutics Stock Split?

XORTX Therapeutics has split 2 times.

How Many Employees Does XORTX Therapeutics Have?

XORTX Therapeutics has 0 employees.

What is the current trading status of XORTX Therapeutics (XRTX)?

As of 07 Aug 2025, XORTX Therapeutics (XRTX) is trading at a price of 0.78, with a previous close of 0.74. The stock has fluctuated within a day range of 0.75 to 0.80, while its 52-week range spans from 0.66 to 2.98.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.